Oocyte activation by calcium ionophore and congenital birth defects: a retrospective cohort study

Comparison between intracytoplasmic sperm injection (ICSI) and calcium ionophore after ICSI treatment reveled no difference in fetal defects, birth weight, gestational week at time of delivery and fetal gender for singleton or twin pregnancies.

Like Comment

Volume 106, Issue 3, Pages 590-596

Authors:

Netanella Miller, M.D., Tal Biron-Shental, M.D., Rivka Sukenik-Halevy, M.D., Anat Hershko Klement, M.D., Reuven Sharony, M.D., Arie Berkovitz, M.D.

Abstract:

Objective

To evaluate the safety of oocyte activation by calcium ionophore in cases of failed fertilization after intracytoplasmic sperm injection (ICSI) procedure with respect to birth defects.

Design

A retrospective cohort of pregnancies achieved by oocyte activation with calcium ionophore after ICSI (ICSI-Ca) and routine ICSI between the years 2006 and 2014.

Setting

Not applicable.

Patient(s)

The cohort included a total of 793 pregnancies: 66 (8%) were lost to follow up and 49 (6%) were ongoing pregnancies at the time of data collection. Out of the 678 available cases for analysis, 595 treatments were ICSI alone (88%) and 83 were ICSI-Ca (12%).

Intervention(s)

None.

Main Outcome Measure(s)

Pregnancy and neonatal outcomes including birth defects were compared.

Result(s)

On the basis of a cohort of 595 ICSI pregnancies and 83 ICSI-Ca pregnancies, we found no difference in birth defects rate for singletons or for twins. Additionally, no significant difference was found between defect type (chromosomal aberration or structural malformations) and malformation type (heart, urogenital, and limb), between the ICSI and ICSI-Ca groups. Moreover, no significant differences were found regarding birth weight, gestational week at time of delivery, and fetal gender for singleton or twin pregnancies.

Conclusion(s)

Ca ionophore oocyte activation should be considered as a legitimate option for cases of failed or low fertilization by ICSI.


Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.